Discovery Capital Management, LLC 13D and 13G filings for Alaunos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 12:43 pm Purchase |
2023-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
Discovery Capital Management, LLC | 400,186 1.660% |
292,279 (+270.86%) |
Filing |
| 2023-02-14 1:18 pm Purchase |
2022-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
Discovery Capital Management, LLC | 107,907 6.730% |
18,930 (+21.28%) |
Filing |
| 2022-02-14 5:06 pm Purchase |
2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
Discovery Capital Management, LLC | 88,977 6.170% |
15,678 (+21.39%) |
Filing |
| 2021-01-07 4:21 pm Purchase |
2020-12-28 | 13G | Alaunos Therapeutics, Inc. TCRT |
Discovery Capital Management, LLC | 73,298 5.130% |
73,298 (New Position) |
Filing |